PATENT CLAIM ANALYSIS

Application Number: 16217360
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "001410"]

Abstract:
Provided herein are antibodies that specifically bind Tau and methods of using the same.

Claim (Index 2):
The monoclonal antibody or antigen-binding fragment according to  claim 1 , wherein:\n the HCDR1 comprises SEQ ID NO: 732, the HCDR2 comprises SEQ ID NO: 734, the HCDR3 comprises SEQ ID NO: 736, the LCDR1 comprises SEQ ID NO: 846, the LCDR2 comprises SEQ ID NO: 848, and the LCDR3 comprises SEQ ID NO: 850 as defined according to the method of Kabat; or the HCDR1 comprises SEQ ID NO: 1002, the HCDR2 comprises SEQ ID NO: 1004, the HCDR3 comprises SEQ ID NO: 1006, the LCDR1 comprises SEQ ID NO: 1116, the LCDR2 comprises SEQ ID NO: 1118, and the LCDR3 comprises SEQ ID NO: 1120 as defined by IMGT.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15559791', '16190676', '14356557', '15699902', '15226744']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7833588804929276
- 35 USC 102 Novelty (BERT): 0.5589144843817345
- Combined Prediction Score: 0.7609144408818083
- Mean Citation Score: 447.975692
- Max Citation Score: 454.3782
- Similarity Product: 338.99457072046994

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test